Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 989-995

  Solter, Philip ^a   Sisson, David ^a   Thomas, William ^a,b   Goetze, Leopold ^a,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALINASE INHIBITOR; N (2 MERCAPTOMETHYL 3 PHENYLPROPIONYL) BETA ALANINE; PLACEBO; SINORPHAN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; DRUG MECHANISM; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; SODIUM ABSORPTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; DOGS; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; KIDNEY; MALE; NEPRILYSIN; PROTEASE INHIBITORS; RENAL CIRCULATION; THIORPHAN;

EID: 0034089062     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ballermann BJ and Brenner BM (1987) Atrial natriuretic peptide and the kidney. Am J Kidney Dis 10:7-12.
2. Berg JA, Hayashi M, Fujii Y and Katz AI (1988) Renal metabolism of atrial natriuretic peptide in the rat. Am J Physiol 255:F466-F473.
3. Borgeson DD, Stevens TL, Heublein DM, Matsuda Y and Burnett JC (1998) Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: Functional cardiorenal responses to receptor antagonism. Clin Sci 95:195-202.
4. Burnett JC Jr, Opgenorth TJ and Granger JP (1986) The renal action of atrial natriuretic peptide during control of glomerular filtration. Kidney Int 30:16-19.
5. Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A and Briscoe TA (1998) Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. J Pharmacol Exp Ther 287:567-577.
6. Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG and Burnett JC Jr (1990) Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation 82:196-201.
7. Davidson WD and Sackner MA (1963) Simplification of the astheme method for the determination of inulin in clearance studies. J Lab Clin Med 62:351-356.
8. Forssmann WG, Richter R and Meyer M (1998) The endocrine heart and natriuretic peptides: Histochemistry, cell biology, and functional aspects of the renal urodilatm system. Histochem Cell Biol 110:335-357.
9. Fried TA, Osgood RW and Stein JH (1988) Tubular site(s) of action of atrial natriuretic peptide in the rat. Am J Physiol 255:F313-F316.
10. Grandclement B and Morel G (1998) Ultrastructural characterization of atrial natriuretic peptide receptors (ANP-R) mRNA expression in rat kidney cortex. Biol Cell 90:213-222.
11. Healy DP and Fanestil DD (1986) Localization of atrial natriuretic peptide binding sites within the rat kidney. Am J Physiol 250:F573-F578.
12. Jougasaki M, Stevens TL, Borgeson DD, Luchner A, Hedfield MM and Burnett JC Jr (1997) Adrenomedullin in experimental congestive heart failure: Cardiorenal activation. Am J Physiol 273:R1392-R1399.
13. Kimura M, Umemura K, Ohashi K and Nakashima M (1998) Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model. Can J Cardiol 14:63-68.
14. Koseki C, Hayashi Y, Torikai S, Furuya M, Ohnuma N and Imai M (1986) Localization of binding sites for alpha-rat atrial natriuretic polypeptide in rat kidney. Am J Physiol 250:F210-F216.
15. Lisy O, Jougasaki M, Schirger JA, Chen HH, Barclay PT and Burnett JC Jr (1998) Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin. Am J Physiol 275:F410-F414.
16. Luchner A, Stevens TL, Borgeson DD, Redfield MM, Bailey JE, Sandberg SM, Heublein DM and Burnett JC Jr (1996) Angiotensin II in the evolution of experimental heart failure. Hypertension 28:472-477.
17. Luchner A, Stevens TL, Borgeson DD, Redfield M, Wei CM, Porter JG and Burnett JC Jr (1998) Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274:H1684-H1689.
18. Margulies KB and Burnett JC Jr (1993) Neutral endopeptidase 24.11: A modulator of natriuretic peptides. Semin Nephrol 13:71-77.
19. Margulies KB, Cavero PG, Seymour AA, Delaney NG and Burnett JC Jr (1990) Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int 38:67-72.
20. Meyer M, Richter R and Forssmann WR (1998) Urodilatin, a natriuretic peptide with clinical implications. Eur J Med Res 3:103-110.
21. Motulsky H (1995) Comparing three or more means: Analysis of variance, in Intuitive Biostatistics, pp 255-262, Oxford University Press, New York.
22. Olins GM, Spear KL, Siegel NR, Reinhard EJ and Zurcher-Neely HA (1987) Atrial peptide inactivation by rabbit-kidney brush-border membranes. Eur J Biochem 170:431-434.
23. Redfield MM, Aarhus LL, Wright RS and Burnett JC Jr (1993) Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation 87:2016-2022.
24. Richards AM, Wittert GA, Espiner EA, Yandle TG, Ikram H and Frampton C (1992) Effect of inhibition of endopeptidase 24.11 on responses to angiotensin II in human volunteers. Circ Res 71:1501-1507.
25. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC and Beaumont A (1993) Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87-146.
26. Shima M, Seino Y, Torikai S and Imai M (1988) Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments. Life Sci 43:357-363.
27. Skott P (1994) Lithium clearance in the evaluation of segmental renal tubular reabsorption of sodium and water in diabetes mellitus. Dan Med Bull 41:23-37.
28. Stevens TL, Rasmussen TE, Wei CM, Kinoshita M, Matsuda Y and Burnett JC Jr (1996) Renal role of the endogenous natriuretic peptide system in acute congestive heart failure. J Card Fail 2:119-125.
29. Takeda S, Kusano E, Murayama N, Asano Y, Hosoda S, Sokabe H and Kawashima H (1986) Atrial natriuretic peptide elevates cGMP contents in glomeruli and in distal tubules of rat kidney. Biochem Biophys Res Commun 136:947-954.
30. Thomson K, Holstein-Rathlou NH and Leyssac PP (1981) Comparison of three measures of proximal tubular reabsorption: Lithium clearance, occlusion time, and micropuncture. Am J Physiol 241:F348-F355.
31. Trapani AJ, Smits GJ, McGraw DE, Spear KL, Koepke JP, Olins GM and Blaine EH (1989) Thiorphan, an inhibitor of endopeptidase 24.11, potentiates the natriuretic activity of atrial natriuretic peptide. J Cardiovasc Pharmacol 14:419-424.
32. Varin J, Duboc D, Weber S, Fouchard J, Schwartz JC, Muffat-Joly M and Guerin F (1991) [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency]. Arch Mol Coeur Vaiss 84:1465-1471.
33. Waugh WH and Beall PT (1974) Simplified measurement of p-aminohippurate and other arylamines in plasma and urine. Kidney Int 5:429-436.
34. Wegner M, Hirth-Dietrich C and Staach JP (1996) Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. Cardiovasc Res 31:891-898.
35. Wilkins MR and Needleman P (1992) Effect of pharmacological manipulation of endogenous atriopeptin activity on renal function. Am J Physiol 262:F161-F167.
36. Wilkins MR, Settle SL, Stockmann PT and Needleman P (1990) Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci USA 87:6465-6469.
37. Willenbrock R, Scheuermann M, Hohnel K, Luft FC and Dietz R (1996) Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. Hypertension 27:1259-1266.
38. Yamamoto K, Burnett JC Jr, Meyer LM, Sinclair L, Stevens TL and Redfield MM (1996) Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model. Am J Physiol 271:R1529-R1534.
39. Yamamoto K, Chappell MC, Brosnihan KB and Ferrario CM (1992) In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats. Hypertension 19:692-696.